Insights from ELCC 2024
Advancing Lung Adenocarcinoma Treatment: Establishing KRAS-Driven Organoids for Drug Screening
By
Insights from ELCC 2024
FEATURING
Isa Tas
By
Insights from ELCC 2024
FEATURING
Isa Tas
Comments 0
Login to view comments.
Click here to Login
